Total Payments
$2,933
2024 Payments
$803.43
Companies
34
Transactions
130
Medicare Patients
1,069
Medicare Billing
$125,460
Payment Breakdown by Category
Food & Beverage$2,917 (99.5%)
Education$15.85 (0.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,917 | 129 | 99.5% |
| Education | $15.85 | 1 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $607.92 | 24 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $493.59 | 21 | $0 (2024) |
| PFIZER INC. | $218.50 | 10 | $0 (2024) |
| GlaxoSmithKline, LLC. | $143.29 | 7 | $0 (2024) |
| Lilly USA, LLC | $142.62 | 7 | $0 (2024) |
| Novo Nordisk Inc | $135.87 | 7 | $0 (2024) |
| Amgen Inc. | $132.57 | 7 | $0 (2022) |
| GENZYME CORPORATION | $121.84 | 1 | $0 (2024) |
| IDORSIA PHARMACEUTICALS US INC | $83.64 | 5 | $0 (2024) |
| Hologic Sales and Service, LLC | $71.61 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $803.43 | 33 | GENZYME CORPORATION ($121.84) |
| 2023 | $741.97 | 28 | AstraZeneca Pharmaceuticals LP ($225.50) |
| 2022 | $553.96 | 29 | ABBVIE INC. ($137.71) |
| 2021 | $735.68 | 35 | AbbVie Inc. ($323.56) |
| 2019 | $17.02 | 1 | Regeneron Healthcare Solutions, Inc. ($17.02) |
| 2018 | $44.61 | 2 | Amgen Inc. ($28.76) |
| 2017 | $36.39 | 2 | Novartis Pharmaceuticals Corporation ($23.63) |
All Payment Transactions
130 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/22/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $23.69 | General |
| Category: IMMUNOLOGY | ||||||
| 11/21/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $21.71 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 11/01/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $19.62 | General |
| Category: Respiratory | ||||||
| 10/23/2024 | Lucid Diagnostics Inc. | — | Food and Beverage | In-kind items and services | $19.88 | General |
| 10/18/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: Diabetes | ||||||
| 10/17/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $19.07 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/30/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.37 | General |
| Category: Diabetes | ||||||
| 09/26/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $20.04 | General |
| Category: Respiratory | ||||||
| 09/23/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: Diabetes | ||||||
| 09/19/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $22.11 | General |
| 09/05/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $25.05 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 08/27/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.70 | General |
| Category: Gastroenterology | ||||||
| 08/22/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $21.67 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/12/2024 | Acella Pharmaceuticals, LLC | NP Thyroid 60 (Drug) | Food and Beverage | In-kind items and services | $14.86 | General |
| Category: Hyperthyroidism | ||||||
| 07/29/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $33.76 | General |
| Category: IMMUNOLOGY | ||||||
| 07/25/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $14.51 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 07/23/2024 | Abbott Laboratories | OCTRODE (Device) | Food and Beverage | In-kind items and services | $22.63 | General |
| Category: Neuromodulation | ||||||
| 07/22/2024 | Hologic Sales and Service, LLC | APTIMA (Device) | Food and Beverage | In-kind items and services | $27.37 | General |
| Category: Diagnostics | ||||||
| 07/11/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $22.83 | General |
| Category: Diabetes | ||||||
| 07/09/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $23.16 | General |
| Category: NEUROSCIENCE | ||||||
| 07/08/2024 | Philips North America LLC | (CK7) Extended Holter (Device) | Food and Beverage | Cash or cash equivalent | $15.65 | General |
| Category: Medical Device | ||||||
| 06/17/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $17.90 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 06/13/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $18.45 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 06/07/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $121.84 | General |
| Category: Immunology | ||||||
| 06/03/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $17.21 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 451 | 614 | $179,045 | $53,378 |
| 2022 | 8 | 328 | 439 | $133,520 | $38,659 |
| 2021 | 9 | 290 | 382 | $103,695 | $33,423 |
Total Patients
1,069
Total Services
1,435
Medicare Billing
$125,460
Procedure Codes
26
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 95 | 138 | $65,550 | $20,434 | 31.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 122 | 211 | $73,325 | $19,136 | 26.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 36 | 36 | $12,600 | $4,985 | 39.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 27 | 45 | $10,125 | $3,397 | 33.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 22 | 22 | $12,100 | $2,676 | 22.1% |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 2023 | 33 | 33 | $1,155 | $895.95 | 77.6% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 33 | 33 | $1,155 | $673.86 | 58.3% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 31 | 31 | $1,085 | $633.02 | 58.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 52 | 65 | $1,950 | $546.00 | 28.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 105 | 176 | $57,200 | $16,560 | 29.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 82 | 118 | $26,550 | $8,163 | 30.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 38 | 38 | $13,050 | $5,369 | 41.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 37 | 37 | $19,975 | $4,916 | 24.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 18 | 19 | $8,975 | $2,131 | 23.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 16 | 16 | $5,200 | $1,314 | 25.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 16 | 16 | $2,000 | $149.42 | 7.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 16 | 19 | $570.00 | $56.10 | 9.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 100 | 169 | $54,925 | $17,762 | 32.3% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 24 | 29 | $12,325 | $4,423 | 35.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 50 | 61 | $13,725 | $4,289 | 31.3% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 19 | 19 | $9,025 | $2,489 | 27.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 14 | 14 | $3,700 | $2,006 | 54.2% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 17 | 17 | $5,525 | $1,286 | 23.3% |
| 90694 | Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage | Office | 2021 | 12 | 12 | $2,400 | $797.16 | 33.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 12 | 12 | $600.00 | $224.88 | 37.5% |
About Dr. Mark Kalina, M.D
Dr. Mark Kalina, M.D is a Internal Medicine healthcare provider based in Solana Beach, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1275638801.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Kalina, M.D has received a total of $2,933 in payments from pharmaceutical and medical device companies, with $803.43 received in 2024. These payments were reported across 130 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($2,917).
As a Medicare-enrolled provider, Kalina has provided services to 1,069 Medicare beneficiaries, totaling 1,435 services with total Medicare billing of $125,460. Data is available for 3 years (2021–2023), covering 26 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Solana Beach, CA
- Active Since 09/14/2006
- Last Updated 09/30/2024
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1275638801
Products in Payments
- UBRELVY (Drug) $317.61
- FARXIGA (Drug) $233.95
- BREZTRI (Drug) $219.98
- VRAYLAR (Drug) $199.41
- NURTEC ODT (Drug) $144.92
- DUPIXENT (Biological) $121.84
- QUVIVIQ (Drug) $83.64
- ELIQUIS (Drug) $75.29
- APTIMA (Device) $71.61
- PAXLOVID (Drug) $69.66
- MOUNJARO (Drug) $67.10
- Ozempic (Drug) $65.57
- QULIPTA (Drug) $64.65
- EMGALITY (Drug) $61.50
- TZIELD (Biological) $57.46
- NUCALA (Biological) $57.45
- Repatha (Biological) $54.36
- LOREEV XR (Drug) $52.40
- Cologuard Collection Kit (Device) $43.91
- ENTRESTO (Drug) $43.41
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Solana Beach
Daniel Pertschuk, M.d, M.D
Internal Medicine — Payments: $193,379
Internal Medicine $193,379
Dr. Blaine Jackson, M.d, M.D
Internal Medicine — Payments: $10,761
Internal Medicine $10,761
Robert Yuhas, Md, MD
Internal Medicine — Payments: $9,625
Internal Medicine $9,625
Heidi Deitch, D.o, D.O
Internal Medicine — Payments: $73.47
Internal Medicine $73.47
Jan Johnston, Md, MD
Internal Medicine — Payments: $71.93
Internal Medicine $71.93
Lawrence Susnow, Md, MD
Internal Medicine
Internal Medicine